- Home
- BCRX vs RLJ Comparison
BCRX vs RLJ Comparison
Compare BCRX & RLJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- RLJ
- Stock Information
- Founded
- BCRX 1986
- RLJ 2011
- Country
- BCRX United States
- RLJ United States
- Employees
- BCRX N/A
- RLJ N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- RLJ Real Estate Investment Trusts
- Sector
- BCRX Health Care
- RLJ Real Estate
- Exchange
- BCRX Nasdaq
- RLJ Nasdaq
- Market Cap
- BCRX 1.7B
- RLJ 1.4B
- IPO Year
- BCRX 1994
- RLJ 2011
- Fundamental
- Price
- BCRX $7.03
- RLJ $9.62
- Analyst Decision
- BCRX Buy
- RLJ Hold
- Analyst Count
- BCRX 6
- RLJ 7
- Target Price
- BCRX $14.67
- RLJ $10.67
- AVG Volume (30 Days)
- BCRX 2.5M
- RLJ 1.8M
- Earning Date
- BCRX 11-04-2024
- RLJ 11-06-2024
- Dividend Yield
- BCRX N/A
- RLJ 4.68%
- EPS Growth
- BCRX N/A
- RLJ N/A
- EPS
- BCRX N/A
- RLJ 0.29
- Revenue
- BCRX $412,579,000.00
- RLJ $1,359,502,000.00
- Revenue This Year
- BCRX $37.24
- RLJ N/A
- Revenue Next Year
- BCRX $19.30
- RLJ $2.83
- P/E Ratio
- BCRX N/A
- RLJ $33.32
- Revenue Growth
- BCRX 29.92
- RLJ 3.89
- 52 Week Low
- BCRX $4.03
- RLJ $8.74
- 52 Week High
- BCRX $8.88
- RLJ $12.39
- Technical
- Relative Strength Index (RSI)
- BCRX 40.38
- RLJ 57.57
- Support Level
- BCRX $6.85
- RLJ $8.74
- Resistance Level
- BCRX $8.25
- RLJ $10.10
- Average True Range (ATR)
- BCRX 0.46
- RLJ 0.30
- MACD
- BCRX -0.08
- RLJ 0.08
- Stochastic Oscillator
- BCRX 11.32
- RLJ 64.34
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About RLJ RLJ Lodging Trust of Beneficial Interest $0.01 par value
RLJ Lodging Trust is a real estate investment trust that acquires focused-service and compact full-service hotels. Its portfolio consists of hotels in various states across the United States and the District of Columbia. Its hotels are under the Marriott, Hilton, and Hyatt brand names. These hotels are concentrated in urban areas, dense suburban markets, and business districts within metropolitan areas. Its revenue streams include hotel operations revenue, which is composed of the sale of rooms, food, and beverages, and other property revenue. The company derives the substantial majority of its revenue from the operation of hotels.